Loading data for ATRC — first visit, this takes a few seconds.

アラート

AtriCure Inc. (ATRC)

NasdaqGM: ATRC · リアルタイム株価 · USD

47.49

-0.12 (-0.25%)

終値時点： Aug 20, 2026, 3:59 PM

47.49

+0.00%

時間外: 7:30 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

-0.25% (1D)

買気配	27.83
時価総額	2.42B
売上高（TTM）	569.62M
純利益（TTM）	10.55M
	1.23
	0.21
	226.14
	109.99
PBR（TTM）	4.68
PSR（TTM）	4.24
決算発表日	May 5, 2026

売気配	49.7
出来高	850,579
平均出来高（20日）	911,774
始値	47.28
前日終値	47.61
当日レンジ	46.70 - 48.46
52週レンジ	25.36 - 48.46
アナリスト	n/a
目標株価	n/a
配当	n/a
権利落ち日	n/a

ATRCについて

AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a ...

[続きを読む]

業種 Medical Instruments & Supplies

セクター Healthcare

IPO日 Aug 5, 2005

従業員数 1,350

上場取引所 NasdaqGM

ティッカー ATRC

ウェブサイト https://www.atricure.com

企業情報の全文

業績

2025年のAtriCureの売上高は534.53Mで、前年の465.31Mから14.88%の増加でした。利益は-11.45Mで、-74.39%の減少でした。

財務諸表

決算サプライズ

AtriCureはJul 23, 2026に四半期決算を発表しました：

売上高は $153.6M で、予想を下回りました $0, うち 12.83% の前年比増加にあたります.

EPSは 0.18 で、予想を上回りました 0.16, うち 228.57% の前年比増加にあたります.

次回決算発表

AtriCure Inc.の決算発表予定日は May 5, 2026, 引け後の予定です。
アナリストの売上高予想は ... アップグレード

ニュース

1週間前 · MarketBeat

AtriCure Targets $1 Billion as Pain Management and AFib Trials Fuel Growth

AtriCure (NASDAQ:ATRC) said it is seeing continued growth across its atrial fibrillation, left atrial appendage management and postsurgical pain-management businesses, supported by new product adoptio...

1週間前 · Motley Fool

Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for Investors

The sale came at $38.42 per share, slightly below the day's market close, as AtriCure maintains its $2.0 billion market cap in the medical device sector.

1週間前 · Motley Fool

An AtriCure Director Sold $905,000 in Stock. Here's How to Read It

Prange's open-market disposition reduced her direct holdings by 14%, though she retains over 22,800 shares in the $2.0 billion medical device company.

2週間前 · Simply Wall St.

Project Horizon and Outlook Upgrade Might Change The Case For Investing In Inspire Medical Systems (INSP)

Inspire Medical Systems recently appointed AtriCure CEO Michael H. Carrel to its Board and committees, while long-serving director Casey M. Tansey plans to retire, as the company reported quarterly re...

3週間前 · Zacks

Are Options Traders Betting on a Big Move in AtriCure Stock?

Investors need to pay close attention to ATRC stock based on the movements in the options market lately.

2ページ中1ページ

AtriCure Inc. (ATRC)